Access cutting-edge advanced/metastatic non-small cell lung cancer treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Denver location
Preparing your pre-screening questions…
Access advanced/metastatic non-small cell lung cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced/metastatic non-small cell lung cancer treatment provided free
Check if you qualify for this advanced/metastatic non-small cell lung cancer clinical trial in Denver, CO
No-Cost Study Care
Local to Denver
Convenient for CO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor is a type of cancer that has spread beyond its original location and cannot be removed by surgery or cured with standard treatments. To join in the study, participants must: * Be 18 years or older * Participants with advanced non-small cell lung cancer (NSCLC), a type of lung cancer that has spread The study will look at: * Whether PF-08634404 is safe to use with other cancer medicines. * What side effects may happen. A side effect is anything the medicine does to your body that is not part of treating your disease. * Whether the combination of PF-08634404 and other cancer medicines can help treat solid tumors. The study has different parts, each testing PF-08634404 with a different cancer medicine: * Part A will test PF-08634404 with a medicine called sigvotatug vedotin. * Part B of the study will look at how well the new medicine PF-08634404 works when used together with another medicine. Participants will receive the study medicines through an intravenous (IV) infusion (injected into the vein) at the study clinic. All treatments will take place at clinical trial sites, where trained medical staff will monitor participants during and after each visit.
Sponsor: Pfizer
Yes, this clinical trial (NCT07227298) has an active research site in Denver, CO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for advanced/metastatic non-small cell lung cancer treatment options in Denver, CO, this clinical trial (NCT07227298) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced/metastatic non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all advanced/metastatic non-small cell lung cancer clinical trials near you to find additional studies recruiting in your area.
See all lung cancer clinical trials recruiting in Denver — not just this study.
Browse Lung Cancer Trials in Denver →